Omada Health, Inc. Payments of Stock Issuance Costs
Omada Health, Inc. (OMDA) reported Payments of Stock Issuance Costs of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-07
- Omada Health, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Omada Health, Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Omada Health, Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was -$1.00K, a 100.09% decline year-over-year.
- Omada Health, Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $2.36M, a 116.24% increase year-over-year.
- Omada Health, Inc. payments of stock issuance costs for fiscal 2025 was $4.28M, a 5.62% decline from fiscal 2024.
- Omada Health, Inc. payments of stock issuance costs for fiscal 2024 was $4.54M, a 3988.29% increase from fiscal 2023.
- Omada Health, Inc. payments of stock issuance costs for fiscal 2023 was $111.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | -$1.00K derived: sum of 3 quarters · filed 2026-08-07 | $2.36M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | -$1.00K derived: sum of 2 quarters · filed 2026-05-08 | $2.36M derived: sum of 3 quarters · filed 2026-05-08 | $3.74M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.36M derived: sum of 2 quarters · filed 2026-03-06 | $3.74M derived: sum of 3 quarters · filed 2026-08-07 | $4.28M 10-K · filed 2026-03-06 |
| 2025-09-30 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.74M derived: sum of 2 quarters · filed 2026-08-07 | $4.28M 10-Q · filed 2025-11-07 | $5.46M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.93M 10-Q · filed 2026-08-07 | $3.10M derived: sum of 3 quarters · filed 2026-08-07 | $4.19M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $547.00K 10-Q · filed 2026-05-08 | $1.72M derived: sum of 2 quarters · filed 2026-05-08 | $2.81M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $2.26M derived: sum of 2 quarters · filed 2026-03-06 | $4.54M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.37M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $2.28M 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $111.00K 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |